NDC 55150-371-01 - Vasopressin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55150-371
- Requested NDC
- 55150-371-01
- Package NDCs from labels
- 55150-371-01, 55150-371-25
- Manufacturer
- AuroMedics Pharma LLC | Par Pharmaceutical Inc.
- Effective date
- 2022-01-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Vasopressin - AuroMedics Pharma LLC | Par Pharmaceutical Inc. | AuroMedics Pharma LLC | Par Pharmaceutical Inc. | 2022-01-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55150-371-01 | ML - Milliliter | 55150-371 | ab74faf3-3b0d-495d-a5ca-fea1cf3e2756 | 1 | 2022-07-06 |
| 55150-371-25 | ML - Milliliter | 55150-371 | abe816e9-5c93-4dce-bc75-dda567afeee6 | 1 | 2022-07-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | 53372911-5a55-dfac-e063-6394a90ae2f6 | 2026-08-17 | Warnings, Adverse reactions | Y87Y826H08 |
| Vasostrict | VASOPRESSIN | Par Health USA, LLC | b1147beb-743e-4c62-8927-91192447f8b8 | 2026-04-21 | Warnings, Adverse reactions | NDA204485 Y87Y826H08 |
| Vasostrict | VASOPRESSIN | Par Health USA, LLC | b97e5c3e-ca28-4ffa-80af-6c5bdbadaf10 | 2026-04-16 | Warnings, Adverse reactions | NDA204485 Y87Y826H08 |
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | f5f03364-e71c-9bcd-e053-2995a90a8ada | 2025-07-11 | Warnings, Adverse reactions | Y87Y826H08 |
| vasopressin | VASOPRESSIN | Medical Purchasing Solutions, LLC | 3532868c-ac1d-43c8-e063-6394a90a4fd1 | 2025-05-15 | Warnings, Adverse reactions | Y87Y826H08 |
| vasopressin | VASOPRESSIN | Dr. Reddy's Laboratories, Inc. | caf04d72-679e-daf9-e86f-4867f83b8ac5 | 2024-07-31 | Warnings, Adverse reactions | Y87Y826H08 |
| Vasostrict | VASOPRESSIN | Medical Purchasin Solutions, LLC | 6672a5c9-bcfd-d7fc-e053-2991aa0aef88 | 2023-06-01 | Warnings, Adverse reactions | NDA204485 Y87Y826H08 |
| Vasostrict | VASOPRESSIN | Medical Purchasing Solutions, LLC | d162d386-105d-e916-e053-2995a90a350c | 2023-05-03 | Warnings, Adverse reactions | NDA204485 Y87Y826H08 |
| a32d0b07-08d5-4ebb-9d1f-40479af5f3d7 | d81ff8fd-5a41-41c6-8b56-10db4788ecfd | 2022-01-23 | Warnings, Adverse reactions | a32d0b07-08d5-4ebb-9d1f-40479af5f3d7 d81ff8fd-5a41-41c6-8b56-10db4788ecfd | ||
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | 7ae1c8c9-7d75-55a8-e053-2991aa0af05b | 2021-11-01 | Warnings, Adverse reactions | NDA204485 Y87Y826H08 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.